Elligo Launches SOAR

Elligo Health Research, a healthcare-enabling research organization, is launching their System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities.

Elligo’s SOAR model expands patient access to reach diverse patient populations that typically don’t have access to clinical research as a care option. The solution drives efficiency by enabling direct data from source to submission and full remote site access, empowering patients, physicians, and sponsors to conduct more trials efficiently and faster in traditional and decentralized models.

“We are extremely excited to launch our tech-enabled solution created to keep the patient and the physician at the heart of its design, while providing sponsors transparency,” said John Potthoff, PhD, CEO of Elligo. “Our goal has always been to provide all patients with access to research as a healthcare option, which is important now more than ever as we navigate the future of clinical research.”